From Biowaste to Lab-Bench: Low-Cost Magnetic Iron Oxide Nanoparticles for RNA Extraction and SARS-CoV-2 Diagnostics

Author:

Yu Le12,Adamson Penelope3,Lay Yap Pei12ORCID,Tung Tran12ORCID,Makar Shaheer124,Turra Mark3,Higgins Geoff3,Losic Dusan12ORCID

Affiliation:

1. School of Chemical Engineering and Advanced Materials, University of Adelaide, Adelaide, SA 5005, Australia

2. ARC Hub for Graphene Enabled Industry Transformation, The University of Adelaide, Adelaide, SA 5005, Australia

3. SA Pathology, Adelaide, SA 5000, Australia

4. Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt

Abstract

The gold standard for diagnostics of SARS-CoV-2 (COVID-19) virus is based on real-time polymerase chain reaction (RT-PCR) using centralized PCR facilities and commercial viral RNA extraction kits. One of the key components of these kits are magnetic beads composed of silica coated magnetic iron oxide (Fe2O3 or Fe3O4) nanoparticles, needed for the selective extraction of RNA. At the beginning of the pandemic in 2019, due to a high demand across the world there were severe shortages of many reagents and consumables, including these magnetic beads required for testing for SARS-CoV-2. Laboratories needed to source these products elsewhere, preferably at a comparable or lower cost. Here, we describe the development of a simple, low-cost and scalable preparation of magnetic nanoparticles (MNPs) from biowaste and demonstrate their successful application in viral RNA extraction and the detection of COVID-19. These MNPs have a unique nanoplatelet shape with a high surface area, which are beneficial features, expected to provide improved RNA adsorption, better dispersion and processing ability compared with commercial spherical magnetic beads. Their performance in COVID-19 RNA extraction was evaluated in comparison with commercial magnetic beads and the results presented here showed comparable results for high throughput PCR analysis. The presented magnetic nanoplatelets generated from biomass waste are safe, low-cost, simple to produce in large scale and could provide a significantly reduced cost of nucleic acid extraction for SARS-CoV-2 and other DNA and RNA viruses.

Funder

Australian research Council

Publisher

MDPI AG

Subject

Clinical Biochemistry,General Medicine,Analytical Chemistry,Biotechnology,Instrumentation,Biomedical Engineering,Engineering (miscellaneous)

Reference34 articles.

1. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin;Zhou;Nature,2020

2. (2022, September 20). WHO Report. Available online: https://covid19.who.int/.

3. A novel coronavirus outbreak of global health concern;Wang;Lancet,2020

4. Laboratory diagnosis of COVID-19: Current issues and challenges;Tang;J. Clin. Microbiol.,2020

5. Diagnostics for SARS-CoV-2 infections;Kevadiya;Nat. Mater.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3